Literature DB >> 26271898

Serum IP-10 in the diagnosis of latent and active tuberculosis.

Vanessa Clifford1, Marc Tebruegge2, Christel Zufferey1, Susie Germano1, Justin Denholm3, Alan Street3, Emma McBryde3, Damon Eisen3, Nigel Curtis4.   

Abstract

Entities:  

Keywords:  Active TB; Diagnostics; IP-10; Latent TB; Tuberculosis

Mesh：

Substances：

Year:  2015        PMID： 26271898     DOI： 10.1016/j.jinf.2015.08.001

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  4 in total

Review 1.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

2.  Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection.

Authors:  Matthew K O'Shea; Rachel Tanner; Julius Müller; Stephanie A Harris; Danny Wright; Lisa Stockdale; Elena Stylianou; Iman Satti; Steven G Smith; James Dunbar; Thomas E Fletcher; Martin Dedicoat; Adam F Cunningham; Helen McShane
Journal:  Sci Rep       Date:  2018-09-27       Impact factor: 4.379

3.  Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.

Authors:  Maho Suzukawa; Shunsuke Akashi; Hideaki Nagai; Hiroyuki Nagase; Hiroyuki Nakamura; Hirotoshi Matsui; Akira Hebisawa; Ken Ohta
Journal:  PLoS One       Date:  2016-04-01       Impact factor: 3.240

4.  Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis.

Authors:  Eveline M Delemarre; Laura van Hoorn; Aik W J Bossink; Julia Drylewicz; Simone A Joosten; Tom H M Ottenhoff; Onno W Akkerman; Delia Goletti; Elisa Petruccioli; Assunta Navarra; Brigitte T A van den Broek; Sanne P A Paardekooper; Ineke van Haeften; Leo Koenderman; Jan-Willem J Lammers; Steven F T Thijsen; Regina W Hofland; Stefan Nierkens
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.